Maier W - Search Results

1

Gene polymorphisms of interleukin-1alpha influence the course of Alzheimer's disease.

Kölsch H, Ptok U, Bagli M, Papassotiropoulos A, Schmitz S, Barkow K, Kockler M, Rao ML, Maier W, Heun R. Kölsch H, et al. Among authors: maier w. Ann Neurol. 2001 Jun;49(6):818-9. doi: 10.1002/ana.1068. Ann Neurol. 2001. PMID: 11409442 No abstract available.

2

A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease.

Papassotiropoulos A, Bagli M, Jessen F, Bayer TA, Maier W, Rao ML, Heun R. Papassotiropoulos A, et al. Among authors: maier w. Ann Neurol. 1999 May;45(5):666-8. doi: 10.1002/1531-8249(199905)45:5<666::aid-ana18>3.0.co;2-3. Ann Neurol. 1999. PMID: 10319892

3

Gene-gene interaction between interleukin-6 and alpha2-macroglobulin influences the risk for Alzheimer's disease.

Bagli M, Papassotiropoulos A, Jessen F, Rao ML, Maier W, Heun R. Bagli M, et al. Among authors: maier w. Ann Neurol. 2000 Jan;47(1):138-9. Ann Neurol. 2000. PMID: 10632118 No abstract available.

4

Gender and AD.

Heun R, Maier W, Müller H. Heun R, et al. Among authors: maier w. Neurology. 1996 Nov;47(5):1357-8. doi: 10.1212/wnl.47.5.1357-a. Neurology. 1996. PMID: 8909475 No abstract available.

5

No association between an intronic polymorphism in the presenilin-1 gene and Alzheimer disease in a German population.

Bagli M, Papassotiropoulos A, Schwab SG, Jessen F, Rao ML, Maier W, Heun R. Bagli M, et al. Among authors: maier w. J Neurol Sci. 1999 Aug 1;167(1):34-6. doi: 10.1016/s0022-510x(99)00131-8. J Neurol Sci. 1999. PMID: 10500259

6

Alpha-1-antichymotrypsin gene polymorphism and risk for sporadic Alzheimer's disease in a German population.

Schwab SG, Bagli M, Papassotiropoulos A, Jessen F, Maier W, Rao ML, Heun R. Schwab SG, et al. Among authors: maier w. Dement Geriatr Cogn Disord. 1999 Nov-Dec;10(6):469-72. doi: 10.1159/000017191. Dement Geriatr Cogn Disord. 1999. PMID: 10559561 Clinical Trial.

7

A genetic variation of cathepsin D is a major risk factor for Alzheimer's disease.

Papassotiropoulos A, Bagli M, Kurz A, Kornhuber J, Förstl H, Maier W, Pauls J, Lautenschlager N, Heun R. Papassotiropoulos A, et al. Among authors: maier w. Ann Neurol. 2000 Mar;47(3):399-403. Ann Neurol. 2000. PMID: 10716266

8

The insulin gene VNTR polymorphism in Alzheimer's disease: results of a pilot study.

Majores M, Kölsch H, Bagli M, Ptok U, Kockler M, Becker K, Rao ML, Maier W, Heun R. Majores M, et al. Among authors: maier w. J Neural Transm (Vienna). 2002 Jul;109(7-8):1029-34. doi: 10.1007/s007020200086. J Neural Transm (Vienna). 2002. PMID: 12111440

9

Genetic polymorphism of cathepsin D is strongly associated with the risk for developing sporadic Alzheimer's disease.

Papassotiropoulos A, Bagli M, Feder O, Jessen F, Maier W, Rao ML, Ludwig M, Schwab SG, Heun R. Papassotiropoulos A, et al. Among authors: maier w. Neurosci Lett. 1999 Mar 12;262(3):171-4. doi: 10.1016/s0304-3940(99)00071-3. Neurosci Lett. 1999. PMID: 10218883

10

Association between an interleukin-6 promoter and 3' flanking region haplotype and reduced Alzheimer's disease risk in a German population.

Bagli M, Papassotiropoulos A, Knapp M, Jessen F, Luise Rao M, Maier W, Heun R. Bagli M, et al. Among authors: maier w. Neurosci Lett. 2000 Apr 7;283(2):109-12. doi: 10.1016/s0304-3940(00)00917-4. Neurosci Lett. 2000. PMID: 10739887

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,944 results

Search Page

Filters